바로가기메뉴

본문 바로가기 주메뉴 바로가기

The Effect of Inhibition of Heme Oxygenase-1 on Chemosensitivity of Cisplatin in Lung Cancer Cells

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2007, v.62 no.1, pp.33-42










  • Downloaded
  • Viewed

Abstract

keywords
Heme oxygenase-1, Cisplatin, Lung Cancer.

Reference

1.

(2004) Nrf2 signaling in coordinated activation of antioxidant gene expression,

2.

(2002) Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription,

3.

(1999) Nrf2, a Cap‘n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene,

4.

(2002) Antioxidants and oxidants regulated signal transduction pathways,

5.

(2000) Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death,

6.

(2000) Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via Nrf2-dependent mechanism,

7.

(2000) Endothelial heme oxygenase-1 induction by hypoxia modulation by inducible nitric-oxide synthase and S-nitrosothiols,

8.

(1999) Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth,

9.

(1998) Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells role of mitogen- activated protein kinases,

10.

(1996) Differential regulation of cardiac heme oxygenase-1 and vascular endothelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxia,

11.

Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation,

12.

(carcinogenesis1992) Endogenous glutathione levels modulate both constitutive and UVA radiation/hydrogen peroxide inducible expression of the human heme oxygenase gene,

13.

(2003) Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts,

14.

(2003) Nitric oxide priming protects nitric oxide-mediated apoptosis via heme oxygenase-1 induction,

15.

(2003) Heme oxygenase and nitric oxide synthasemediate cooling-associated protection against TNF-alpha-induced microcirculatory dysfunction and apoptotic cell death,

16.

(2002) Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro,

17.

(1997) Overexpression of the heme oxygenase gene in renal cell carcinoma,

18.

(1996) Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution,

19.

(2002) Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor- targeting capacity,

20.

(2006) The role of heme oxygenase-1 in lung cancer cells,

21.

(2004) Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer,

22.

(2006) Flunarizine induces Nrf2-mediated transcriptional activation of heme oxygenase-1 in protection of auditory cells from cisplatin,

23.

(2006) Heme oxygenase-1 attenuates the cisplatin-induced apoptosis of auditory cells via down-regulation of reactive oxygen species generation,

24.

(2004) Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin,

25.

(pharmacolther1987) isolation and characterization of DNA adducts produced by anticancer platinum complexes,

26.

Mechanism of cis-diamminedichloroplatinum role of G2 arrest and DNA double-strand breaks,

27.

(2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance,

28.

(2004) Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production,

29.

(2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway,

30.

(2003) Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury,

31.

(1999) Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis,

32.

(2000) Heme oxygenase (HO)-1 expressing macrophages/microglial cells accumulate during oligodendroglioma progression,

33.

(2000) Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas,

34.

(2003) In vivo antitumor activity of pegylated zinc protoporphyrin targeted inhibition of heme oxygenase in solid tumor,

35.

(2004) Antiapoptotic role of heme oxygnease (HO) and the potential of HO as a target in anticancer treatment,

36.

(2006) Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by EGCG,

37.

(2006) Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity,

38.

(2003) Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour,

39.

(2005) Heme oxygenase-1 accelerates protumoral effects of nitric oxide in cancer cells,

40.

(2001) The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs),

41.

(1996) The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat,

42.

(1998) Cisplatin induces a persistent activation of JNK that is relatedto cell death,

Tuberculosis & Respiratory Diseases